A team of researchers affiliated with multiple institutions in Finland and one in the Czech Republic has found that replacing asphalt in play areas at daycare centers with natural vegetation can lead to stronger immune defenses ...
A one-two punch of changing gene expression, then deploying immune checkpoint inhibitors, shows promise in battling one of the most treatment-resistant types of cancer in preclinical models, according to a new publication ...
Sep 30, 2020
0
8
A comprehensive search of genetic variation databases has revealed no significant differences across populations and ethnic groups in seven genes associated with viral entry of SARS-CoV-2.
Sep 24, 2020
0
29
Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental ...
Sep 14, 2020
0
9
Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system ...
Sep 8, 2020
0
6
NIMS has developed a low-cost self-assembled particle-based injectable gel for promoting blood vessel formation—a regenerative medicine process vital in cell and tissue transplantation. This material may be used as an effective, ...
Sep 1, 2020
0
3
Animals and humans have the ability to follow their own position in space through self-motion cues, even in the absence of any other sensory information. "If you get up at night and want to find your way to the bathroom in ...
Aug 31, 2020
0
67
New research in mice highlights the potential protective effect of microglia—a type of non-neuronal cell in the brain—against overactivation of the central nervous system during acute epileptic seizures. The study is ...
Aug 28, 2020
0
32
An international collaboration of researchers across more than 80 countries has come to the conclusion that chloroquine (CQ) and hydroxchloroquine (HCQ) are unlikely to provide clinical benefit against COVID-19. In a new ...
Aug 27, 2020
3
1794
Promising early stage results from a phase 1/2 clinical trial of the UK's vaccine candidate against SARS-CoV-2 (the virus that causes COVID-19) are published today in The Lancet.
Jul 20, 2020
0
47
